NRX101 Glx Biomarker Validation Study

Clinical trial NCT03402152 · COMPLETED

Trial details

NCT number: NCT03402152
Sponsor: NeuroRx, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Bipolar Depression Suicidal Ideation

Start date: 2018-11-01
Primary completion: 2021-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.